Skip to content

A single center randomized clinical controlled study on the effectiveness of traditional Chinese medicine for dispelling dampness in the treatment of influenza dampness syndrome

A single center randomized clinical controlled study on the effectiveness of traditional Chinese medicine for dispelling dampness in the treatment of influenza dampness syndrome

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000662
Enrollment
Unknown
Registered
2025-04-06
Start date
2024-04-23
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

treatment group:Qingjie granule
treatment group:Qingjie granule +Oseltamivir
treatment group:Compound Elsholtzia Liquid

Sponsors

Guangzhou Eighth Peoples Hospital Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: To observe the effectiveness of Compound Elsholtzia Liquid Huoxiang Zhengqi oral liquid and Qingjie granule in treating influenza dampness syndrome.

Exclusion criteria

Exclusion criteria: (1)Pregnant and lactating women (2)Patients with the following diseases or conditions : pneumonia suppurative tonsillitis acute tracheobronchitis acute pharyngitis acute exacerbation of nasal diseases ( such as allergic rhinitis chronic rhinitis acute and chronic sinusitis etc. ) chronic respiratory diseases ( such as chronic obstructive pulmonary disease interstitial lung disease etc. ) asthma tuberculosis ; severe primary diseases such as heart brain lung liver kidney and blood system such as unstable control / severe complications of diabetes viral hepatitis hemophilia ; mental illness ; immunosuppressive status ( including immunosuppressive agents or HIV infection ) ; (3)Allergic to alcohol and test drug ingredients (4)Those who had been vaccinated against influenza within 1 year (5)Those who had taken antibiotics and proton pump inhibitors in the past 1 month ; (6)After the onset of the diseasewho took anti-influenza virus drugsor traditional chinese medicine with the same function of the test drug.

Design outcomes

Primary

MeasureTime frame
Clinical recovery time;

Secondary

MeasureTime frame
virus negative conversion ratio;IL-6;Fecal microbiota detection;blood routine+CRP;Improvement of single syndrome of traditional Chinese medicine;complete cooling time;Antipyretic onset time;Complications and severe rate;

Countries

China

Contacts

Public ContactXiemin

Guangzhou Eighth Peoples Hospital Guangzhou Medical University

gz8hxiemin@126.com020-36052110

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026